Kiniksa Pharmaceuticals International Plc (KNSA)
42.20
-0.24
(-0.57%)
USD |
NASDAQ |
Jan 23, 16:00
42.16
-0.04
(-0.09%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Research and Development Expense (TTM): 97.30M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 14.74M |
| NovoCure Ltd. | 214.85M |
| LivaNova Plc | 176.94M |
| ADMA Biologics, Inc. | 3.776M |
| Akanda Corp. | -- |